Bardet-Biedl Syndrome Clinical Trial
Official title:
Bardet-Biedl Syndrome: Clinical and Genetic Epidemiology Study in the Adults
This study is based on the study of the natural history of a rare disorder: the Bardet-Biedl syndrome (BBS) (which is associated with retinitis pigmentosa, polydactyly, cognitive impairment, obesity, and kidney failure). The clinical, biological, and radiological features of adult patients are studied. In parallel, a molecular study is performed on the known genes to date (8 genes from BBS1 to BBS8) and to identify new genes involved. The parts of the study are combined in a phenotype-genotype correlation study.
n/a
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04874909 -
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)
|
N/A | |
| Recruiting |
NCT02329210 -
Clinical Registry Investigating Bardet-Biedl Syndrome
|
||
| Recruiting |
NCT02435940 -
Inherited Retinal Degenerative Disease Registry
|
||
| Recruiting |
NCT04461444 -
COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study
|
N/A | |
| Recruiting |
NCT06239064 -
Early Genetic Identification of Obesity
|
||
| Terminated |
NCT00078091 -
Genetics and Clinical Characteristics of Bardet-Biedl Syndrome
|
||
| Completed |
NCT04966741 -
Setmelanotide in Pediatric Patients With Rare Genetic Diseases of Obesity
|
Phase 3 | |
| Enrolling by invitation |
NCT05400278 -
Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome
|
||
| Completed |
NCT05194124 -
Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Patients With Specific Gene Defects in the MC4R Pathway
|
Phase 3 | |
| Withdrawn |
NCT03490019 -
Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement
|
Phase 2 |